口服组胺H1受体拮抗剂在儿童中合理应用的 临床实践指南计划书

Rational use of oral H1 receptor antagonists in children:a clinical practice guideline protocol

本指南计划书详细介绍《口服组胺H1受体拮抗剂在儿童中合理应用的临床实践指南》制订的各个关键环节的方法、流程和注意事项。参考《世界卫生组织指南制订手册》,按照指南制订的标准化流程进行指南项目组的筹建(包括指导委员会、指南专家组、指南秘书组、指南外审组和患者家属组)、指南注册(注册号:IPGRP-2020CN110)、临床问题的与结局指标的收集与确定、证据的检索、评价整合与利用、推荐意见的形成和外审、推荐意见的修订、指南的撰写与发布、指南的后效评价与更新等步骤,旨在为科学和循证制订临床指南提供纲要性和指导性的实施方案。

The protocol of rational use of oral H1 receptor antagonists in children:a clinical practice guideline primarily introduces key methods,processes and precautions of the guideline to standardize and guarantee the formulation of this evidence-based guideline.Referring to the World Health Organization Guidelines Development Manual,the guideline will be conducted according to the following steps,which involves the establishment of project group;registration(IPGRP-2020CN110);declaration of interest and funding support;identification of the clinical issues and outcomes;evidence retrieval,assessment,synthesis and utilization;investigation of patients’preferences and values;development,external review and revision of recommendations;guideline release,dissemination and update.